CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep. 29, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
Read MoreNew England Journal of Medicine Publishes Positive Results of the Pivotal Trial of Cablivi (caplacizumab) for Rare Blood Clotting Disorder
PARIS, Jan. 9, 2019 /PRNewswire/ — The New England Journal of Medicine (NEJM) today published positive results of the Phase…
Read More